Label: PRIMATENE- ephedrine hydrochloride tablet

  • NDC Code(s): 80070-600-24, 80070-600-60
  • Packager: Foundation Consumer Brands
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated January 25, 2021

If you are a consumer or patient please visit this version.

  • SPL UNCLASSIFIED SECTION

    Drug Facts

  • Active ingredient (in each tablet)

    Ephedrine HCl 12.5 mg

  • Purpose

    Bronchodilator

  • Use

    • for temporary relief of mild symptoms of intermittent asthma:
      • wheezing
      • tightness of chest
      • shortness of breath
  • Warnings

    Asthma alert

    Because asthma may be life threatening, see a doctor if you

    • are not better in 60 minutes
    • get worse
    • need more than 12 tablets in 24 hours
    • use more than 8 tablets in 24 hours for 3 or more days a week
    • have more than 2 asthma attacks in a week
      These may be signs that your asthma is getting worse.
    • This product will not give you asthma relief as quickly as an inhaled bronchodilator.

    Do not use

    • unless a doctor said you have asthma
    • if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs taken for depression, psychiatric or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
    • if you have ever had an allergic reaction to this product or any of its ingredients

    Ask a doctor before use if you have

    • ever been hospitalized for asthma
    • heart disease
    • high blood pressure
    • diabetes
    • thyroid disease
    • seizures
    • narrow angle glaucoma
    • a psychiatric or emotional condition
    • trouble urinating due to an enlarged prostate gland

    Ask a doctor or pharmacist before use if you are

    • taking prescription drugs for asthma, obesity, weight control, depression, or psychiatric or emotional conditions
    • taking any drug that contains phenylephrine, pseudoephedrine, ephedrine, or caffeine (such as for allergy, cough-cold, or pain)

    When using this product

    • your blood pressure or heart rate may go up. This could increase your risk of heart attack or stroke, which may cause death.
    • your risk of heart attack or stroke increases if you:
      • have a history of high blood pressure or heart disease
      • take this product more frequently or take more than the recommended dose
    • avoid foods or beverages that contain caffeine
    • avoid dietary supplements containing ingredients reported or claimed to have a stimulant effect

    Stop use and ask a doctor if

    • your asthma is getting worse (see Asthma alert)
    • you have difficulty sleeping
    • you have a rapid heart beat
    • you have tremors, nervousness, or seizure

    If pregnant or breast-feeding, ask a health professional before use.

    Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

  • Directions

    • do not take more than directed
    • adults and children 12 years and over: take 1-2 tablets every 4 hours as needed. Do not take more than 12 tablets in 24 hours.
    • children under 12 years of age: do not use
  • Other information

    • store at 20-25°C (68-77°F)
  • Inactive ingredients

    D&C yellow #10 aluminum lake, dibasic calcium phosphate dihydrate, FD&C yellow #6 aluminum lake, magnesium stearate, microcrystalline cellulose, silicon dioxide, sodium starch glycolate, stearic acid

  • Questions or comments?

    Call 1-800-535-0026 weekdays 9 AM to 5 PM EST

  • SPL UNCLASSIFIED SECTION

    Distributed by:
    Foundation Consumer Brands, LLC
    Pittsburgh, PA 15212

  • PRINCIPAL DISPLAY PANEL - 12.5 mg Tablet Blister Pack Carton

    NEW FORMULA

    Primatene®
    TABLETS

    Ephedrine HCl 12.5 mg • Bronchodilator

    For the Temporary Relief of Mild Symptoms of
    INTERMITTENT ASTHMA

    24 TABLETS

    PRINCIPAL DISPLAY PANEL - 12.5 mg Tablet Blister Pack Carton
  • INGREDIENTS AND APPEARANCE
    PRIMATENE 
    ephedrine hydrochloride tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:80070-600
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    EPHEDRINE HYDROCHLORIDE (UNII: NLJ6390P1Z) (EPHEDRINE - UNII:GN83C131XS) EPHEDRINE HYDROCHLORIDE12.5 mg
    Inactive Ingredients
    Ingredient NameStrength
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)  
    D&C YELLOW NO. 10 ALUMINUM LAKE (UNII: CQ3XH3DET6)  
    FD&C YELLOW NO. 6 (UNII: H77VEI93A8)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  
    STEARIC ACID (UNII: 4ELV7Z65AP)  
    Product Characteristics
    ColorYELLOW (Light yellow color) Scoreno score
    ShapeROUNDSize8mm
    FlavorImprint Code PT;in;circle;engraved
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:80070-600-242 in 1 CARTON01/22/2021
    112 in 1 BLISTER PACK; Type 0: Not a Combination Product
    2NDC:80070-600-605 in 1 CARTON01/22/2021
    212 in 1 BLISTER PACK; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC MONOGRAPH FINALpart34101/22/2021
    Labeler - Foundation Consumer Brands (117603632)